IL-22-dependent attenuation of T cell-dependent (ConA) hepatitis in herpes virus entry mediator deficiency

Journal of Immunology

Volumn 182, Issue 8, 2009, Pages 4521-4528

  Wahl, Christian ^a   Wegenka, Ursula Maria ^a   Leithäuser, Frank ^a   Schirmbeck, Reinhold ^a   Reimann, Jörg ^a  

^a UNIVERSITY OF ULM   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CONCANAVALIN A; GAMMA INTERFERON; HERPESVIRUS ENTRY MEDIATOR LIGAND; INTERLEUKIN 22; INTERLEUKIN 4; HERPESVIRUS ENTRY MEDIATOR; INTERLEUKIN DERIVATIVE; INTERLEUKIN-22;

ACUTE HEPATITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE MARROW; CD3+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CELLULAR IMMUNITY; CHIMERA; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; DISEASE EXACERBATION; FEMALE; HISTOPATHOLOGY; MALE; MOUSE; NATURAL KILLER T CELL; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; T LYMPHOCYTE; T LYMPHOCYTE SUBPOPULATION; WILD TYPE; ANIMAL; BLOOD; DRUG EFFECT; GENETICS; HEPATITIS; IMMUNOLOGY; METABOLISM; MOUSE MUTANT;

ANIMALS; CONCANAVALIN A; HEPATITIS; INTERLEUKINS; MICE; MICE, KNOCKOUT; RECEPTORS, TUMOR NECROSIS FACTOR, MEMBER 14; T-LYMPHOCYTES;

EID: 65249157457     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.0802810     Document Type: Article

References (25)

1. Tiegs, G., J. Hentschel, and A. Wendel. 1992. A T cell-dependent experimental liver injury in mice inducible by concanavalin A. J. Clin. Invest. 90: 196-203.
2. + T cells for concanavalin A-induced hepatic injury in mice. J. Immunol. 159: 1537-1542.
3. Mizuhara, H., E. O'Neill, N. Seki, T. Ogawa, C. Kusunoki, K. Otsuka, S. Satoh, M. Niwa, H. Senoh, and H. Fujiwara. 1994. T cell activation-associated hepatic injury: mediation by tumor necrosis factors and protection by interleukin 6. J. Exp. Med. 179: 1529-1537. (Pubitemid 24129570)
4. Gantner, F., M. Leist, A. W. Lohse, P. G. Germann, and G. Tiegs. 1995. Concanavalin A-induced T-cell-mediated hepatic injury in mice: the role of tumor necrosis factor. Hepatology 21: 190-198.
5. Leist, M., F. Gantner, G. Kunstle, I. Bohlinger, G. Tiegs, H. Bluethmann, and A. Wendel. 1996. The 55-kD tumor necrosis factor receptor and CD95 independently signal murine hepatocyte apoptosis and subsequent liver failure. Mol. Med. 2: 109-124. (Pubitemid 26422034)
6. Tagawa, Y., S. Kakuta, and Y. Iwakura. 1998. Involvement of Fas/Fas ligand system-mediated apoptosis in the development of concanavalin A-induced hepatitis. Eur. J. Immunol. 28: 4105-4113. (Pubitemid 28558640)
7. Kaneko, Y., M. Harada, T. Kawano, M. Yamashita, Y. Shibata, F. Gejyo, T. Nakayama, and M. Taniguchi. 2000. Augmentation of Vα14 NKT cell-mediated cytotoxicity by interleukin 4 in an autocrine mechanism resulting in the development of concanavalin A-induced hepatitis. J. Exp. Med. 191: 105-114. (Pubitemid 30043652)
8. Zhu, R., S. Diem, L. M. Araujo, A. Aumeunier, J. Denizeau, E. Philadelphe, D. Damotte, M. Samson, P. Gourdy, M. Dy, E. Schneider, and A. Herbelin. 2007. The pro-Th1 cytokine IL-12 enhances IL-4 production by invariant NKT cells: relevance for T cell-mediated hepatitis. J. Immunol. 178: 5435-5442. (Pubitemid 46674337)
9. Louis, H., A. Le Moine, V. Flamand, N. Nagy, E. Quertinmont, F. Paulart, D. Abramowicz, O. Le Moine, M. Goldman, and J. Deviere. 2002. Critical role of interleukin 5 and eosinophils in concanavalin A-induced hepatitis in mice. Gastroenterology 122: 2001-2010. (Pubitemid 34651442)
10. Faggioni, R., J. Jones-Carson, D. A. Reed, C. A. Dinarello, K. R. Feingold, C. Grunfeld, and G. Fantuzzi. 2000. Leptin-deficient (ob/ob) mice are protected from T cell-mediated hepatotoxicity: role of tumor necrosis factor α and IL-18. Proc. Natl. Acad. Sci. USA 97: 2367-2372. (Pubitemid 30134075)
11. Anand, S., P. Wang, K. Yoshimura, I. H. Choi, A. Hilliard, Y. H. Chen, C. R. Wang, R. Schulick, A. S. Flies, D. B. Flies, et al. 2006. Essential role of TNF family molecule LIGHT as a cytokine in the pathogenesis of hepatitis. J. Clin. Invest. 116: 1045-1051.
12. + T cell- and STAT3-dependent manners. J. Immunol. 172: 5648-5655.
13. Louis, H., O. Le Moine, M. O. Peny, E. Quertinmont, D. Fokan, M. Goldman, and J. Deviere. 1997. Production and role of interleukin-10 in concanavalin Ainduced hepatitis in mice. Hepatology 25: 1382-1389. (Pubitemid 27250758)
14. Di Marco, R., M. Xiang, P. Zaccone, C. Leonardi, S. Franco, P. Meroni, and F. Nicoletti. 1999. Concanavalin A-induced hepatitis in mice is prevented by interleukin (IL)-10 and exacerbated by endogenous IL-10 deficiency. Autoimmunity 31: 75-83. (Pubitemid 30110396)
15. Yamanaka, A., S. Hamano, Y. Miyazaki, K. Ishii, A. Takeda, T. W. Mak, K. Himeno, A. Yoshimura, and H. Yoshida. 2004. Hyperproduction of proinflammatory cytokines by WSX-1-deficient NKT cells in concanavalin A-induced hepatitis. J. Immunol. 172: 3590-3596. (Pubitemid 38337940)
16. Zenewicz, L. A., G. D. Yancopoulos, D. M. Valenzuela, A. J. Murphy, M. Karow, and R. A. Flavell. 2007. Interleukin-22 but not interleukin-17 provides protection to hepatocytes during acute liver inflammation. Immunity 27: 647-659.
17. Gavrieli, M., J. Sedy, C. A. Nelson, and K. M. Murphy. 2006. BTLA and HVEM cross talk regulates inhibition and costimulation. Adv. Immunol. 92: 157-185. (Pubitemid 44828119)
18. Wang, Y., S. K. Subudhi, R. A. Anders, J. Lo, Y. Sun, S. Blink, Y. Wang, J. Wang, X. Liu, K. Mink, et al. 2005. The role of herpesvirus entry mediator as a negative regulator of T cell-mediated responses. J. Clin. Invest. 115: 711-717. (Pubitemid 40322246)
19. Sutton, C., C. Brereton, B. Keogh, K. H. Mills, and E. C. Lavelle. 2006. A crucial role for interleukin (IL)-1 in the induction of IL-17-producing T cells that mediate autoimmune encephalomyelitis. J. Exp. Med. 203: 1685-1691. (Pubitemid 44036274)
20. Bettelli, E., M. Oukka, and V. K. Kuchroo. 2007. T(H)-17 cells in the circle of immunity and autoimmunity. Nat. Immunol. 8: 345-350.
21. Liang, S. C., X. Y. Tan, D. P. Luxenberg, R. Karim, K. Dunussi-Joannopoulos, M. Collins, and L. A. Fouser. 2006. Interleukin (IL)-22 and IL-17 are coexpressed by Th17 cells and cooperatively enhance expression of antimicrobial peptides. J. Exp. Med. 203: 2271-2279.
22. Wahl, C., P. Bochtler, R. Schirmbeck, and J. Reimann. 2007. Type I IFN-producing CD4 Vα14i NKT cells facilitate priming of IL-10-producing CD8 T cells by hepatocytes. J. Immunol. 178: 2083-2093. (Pubitemid 46233405)
23. Zheng, Y., D. M. Danilenko, P. Valdez, I. Kasman, J. Eastham-Anderson, J. Wu, and W. Ouyang. 2007. Interleukin-22, a T(H)17 cytokine, mediates IL-23-induced dermal inflammation and acanthosis. Nature 445: 648-651. (Pubitemid 46232884)
24. Andersson, J., K. O. Gronvik, E. L. Larsson, and A. Coutinho. 1979. Studies on T lymphocyte activation. I. Requirements for the mitogen-dependent production of T cell growth factors. Eur. J. Immunol. 9: 581-587. (Pubitemid 10225204)
25. Stetson, D. B., M. Mohrs, R. L. Reinhardt, J. L. Baron, Z. E. Wang, L. Gapin, M. Kronenberg, and R. M. Locksley. 2003. Constitutive cytokine mRNAs mark natural killer (NK) and NK T cells poised for rapid effector function. J. Exp. Med. 198: 1069-1076.